Kathryn Mikkelsen on The Beat: Vasculearn Network’s Newsletter for Clot Survivors
Kathryn Mikkelsen, Executive Director at Vasculearn Network, shared on LinkedIn:
”Ever find yourself thinking, “I wish there were a great, free resource I could point my patient—or a family member or friend—to” after a diagnosis of a vascular health condition—such as a blood clot, high cholesterol, atrial fibrillation, or stroke?
That’s exactly why we created The Beat, Vasculearn Network‘s free newsletter for patients, caregivers, and anyone interested in vascular health.
It’s designed to support people after a diagnosis, as well as those looking to better understand vascular conditions and their care.
The Beat covers timely, practical topics in vascular health, offering clear, patient-centered education that clinicians can confidently share beyond the clinic visit.
It’s easy to share and easy to access:
• Available in print
• Read online
• Or listened to directly on our website
If you’re looking for a simple way to extend education beyond the clinic—or to support someone you care about—this is a great place to start.
Sign up or share here.”
Stay updated with Hemostasis Today.
-
Mar 17, 2026, 15:34Folusho Adeosun: Raising Fetal Hemoglobin as a Powerful Protective Shield in Sickle Cell Disease
-
Mar 17, 2026, 15:28Aafreen Kotadiya: Why a Great Blood Bank Team is a Rare and Powerful Asset in Transfusion Medicine
-
Mar 17, 2026, 15:26Nathan Connell: $50 Million Gift to Advance Cell and Gene Therapy at Mass General Brigham
-
Mar 17, 2026, 15:10Peter Zdziarski: Standing Together for Ultra Rare Bleeding Disorders Awareness Day
-
Mar 17, 2026, 14:58Heghine Khachatryan: PFO, Cryptogenic Stroke, and Factor V Leiden – Closure or Lifelong Anticoagulation?
-
Mar 17, 2026, 14:56Mahesan Subramaniam: A Visual Guide to Heart Valve Disease
-
Mar 17, 2026, 14:55Daniel Victor Ortigoza: Apixaban Shows Lower Bleeding Risk than Rivaroxaban in Acute VTE
-
Mar 17, 2026, 14:52Kanishk Kumar: ATTR Amyloidosis Therapeutics Market Poised for a Pipeline Revolution
-
Mar 17, 2026, 14:39Giordano Botta: VA and Allelica Partner on Clinical Study of PRS and PGx in Cardiovascular Prevention